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Abstract
Wound healing is a complicated biological process consisting of many types of cellular dy-
namics and functions regulated by chemical and molecular signals. Recent advances in synthetic
biology have made it possible to predictably design and build closed-loop controllers that can
function appropriately alongside biological species. In this paper we develop a simple dynamical
population model mimicking the sequential relay-like dynamics of cellular populations involved
in the wound healing process. Our model consists of four nodes and five signals whose pa-
rameters we can tune to simulate various chronic healing conditions. We also develop a set of
regulator functions based on type-1 incoherent feed forward loops (IFFL) that can sense the
change from acute healing to incomplete chronic wounds, improving the system in a timely
manner. Both the wound healing and type-1 IFFL controller architectures are compatible with
available synthetic biology experimental tools for potential applications.
Introduction
Wound healing is a dynamical, multi-cellular process regulated by a complicated network of prop-
agating cell signals [1]. A healthy response to tissue injury relies on a systematic cascade of events
known as acute wound healing. Acute healing is classically defined by four consecutive phases dis-
tinct in function and histological characteristics: the hemostasis phase involving blood coagulation,
the inflammatory phase in which the wound is debrided of foreign material, the proliferation phase
when granulation tissue forms and the wound closes, and finally the remodelling phase which in-
cludes improving the tensile strength of the wound [2]. Together, the phases demonstrate relay-like
dynamics of cellular densities and functions, coordinated by the secretion of various signals [3, 4].
Some of the more prominent cells involved in wound healing are platelets, neutrophils, macrophages,
fibroblasts, and endothelial cells. The sequential flow of varying cell populations into the wound,
illustrated in Figure 1A, is carried out by a combination of cell migration, infiltration, proliferation,
and differentiation. It is also controlled by an equally sophisticated signaling network of growth fac-
tors, cytokines, and chemokines [5, 6]. Platelets are the first cell type to enter the wound, beginning
at the moment of injury. Platelets promote the formation of blood clots, activate coagulation, and
recruit various inflammatory cells into the wound by releasing pro-inflammatory growth factors [7]
and cytokines.
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As the first circulating inflammatory cells to enter the site of injury, neutrophils overtake
platelets as the predominant cell in the wound, protecting the host from pathogenic infections.
Neutrophils secrete antimicrobial proteins that help degrade potential pathogens and produce pro-
inflammatory signals for self-proliferation and macrophage migration into the wound [8]. Macrophages
continue the cleaning of the wound by microbial phagocytosis and the digestion of cellular debris.
As more monocytes differentiate into macrophages, the once dominant neutrophil populations de-
crease due to pro-apoptotic endogenous signals of mature neutrophils [9, 10, 11]. By the time the
inflammatory cycle ends, the macrophage-derived growth factors reach the optimal level causing
an influx of fibroblasts into the wound [12, 13].
During the proliferation phase, fibroblast and epithelial cells are the most prominent cell types
present. As fibroblasts continue to migrate into the wound, components of the extra-cellular
matrix (ECM) including collagen, are produced, promoting wound closure and increasing tensile
strength [14]. Following proliferation and ECM formation, healing enters the remodelling phase.
In some cases, the remodelling phase can last many years as the collagen and granulation tissues
are constantly being reorganized. Also during the remodelling phase, fibroblasts differentiate into
contractile myofibroblasts resulting in minimal scar tissue and preserved tissue function [15].
Even in the simplified description above, it is easy to appreciate the complexity and coordination
of the healing process. When deviations from the acute process occurs, healing is delayed, and
ften times chronic, non-healing wounds persist. Chronic wounds are often difficult to treat due
to the large array of molecular and cellular pathology within the chronic environment [16, 17].
Effective therapeutics must be coordinated temporally and molecularly to regulate altered signals
appropriately.
Here, we present a multi-layer control strategy for an engineered healing regulator system. The
first layer is designed to mimic cellular population dynamics of acute healing with tunable param-
eters for induced chronic wound healing. The second layer regulates against chronic conditions
via pulse signals from activated cell types. We show that a type-1 pulse generating incoherent
feed-forward loop (IFFL) architecture is an effective design choice for our desired functions.
Wound healing design strategy
Our proposed wound healing circuit is an abstraction of physiological wound healing focusing on
only a few of many well studied cell types of known importance and characterized dynamics: neu-
trophils (C1), macrophages (C2), fibroblasts (C3) and myofibroblasts (C4), illustrated in Figure 1A
and B. The dynamics of the skin healing cascade depend heavily on the population of each cell type
and the major chemical mediators developed in each phase. From the proposed circuit diagram in
Figure 1, we developed a deterministic model of two coupled negative feedback modules producing
sequential pulses of signals resembling the physiological acute healing process dynamics.
We analyzed the progression of healing by the population dynamics of each of the four cell
types over time. Our goal is to eventually extend this computational model to an experimental
demonstration of wound healing using engineered E. coli as our cellular chassis. Therefore, our
design strategies are based on bacterial implementation and dynamics. Table 1 summarizes the
species involved in the mechanisms described in the subsequent sections. Table 2 summarizes the
parameters used to simulate acute wound healing dynamics in a bacterial system.
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Figure 1: Simulating the wound healing dynamics with a reduced model. A. Diagram
of wound healing signal and cell propagation dynamics. Upon injury the hemostasis stage occurs,
preventing further blood loss via platelet activation. Platelets release chemokines and other growth
factors, recruiting neutrophils into the wound. Neutrophils are the first inflammatory cell type to
enter the wound. Mature neutrophils undergo apoptosis, releasing signals to recruit macrophages.
Macrophages continue the debridement process of the wound consuming non-active neutrophils
and release signals to promote the migration of fibroblasts. The presence of fibroblasts corresponds
with the proliferation phase. As the extra-cellular matrix (ECM) is reconstructed, various proteins
and chemical signals released by the ECM activate macrophage differentiation from M1 to M2, as
well as the differentiation of fibroblasts to myofibroblasts. B. Circuit diagram used to demonstrate
acute wound healing computationally. C1 = Neutrophils; C2 = Macrophages; C3 = Fibroblasts;
C4 = Myofibroblasts/Collagen. A1 and A3 are signals for growth; A2 and A4 are signals for death.
C. Simulation of acute wound healing dynamics using parameters listed in Table 2 and ODEs in
equations (1-8).
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Acute wound healing dynamics
To simplify the model, cell proliferation, migration (in), and infiltration are modeled as cell growth;
while apoptosis, phagocytosis, cell migration (out), and, in the case of macrophage dynamics, cell
differentiation are modeled as cell death. All communication signals (species A1, A2, A3 and A4)
are modeled as quorum sensing molecules that permeate through cell walls instantly. The topology
of the circuit design is illustrated in Figure 1B.
The minimal model for our wound healing dynamics simulations, are based on the following
assumptions:
• Every cell in the population of a given cell type contains identical circuit function; the acti-
vation of either cell growth or cell death is triggered by two orthogonal signals.
• Cell growth has logistic kinetics with a growth rate constant of gCi and a carrying capacity of
Cmax. The growth rate of Ci is proportional to the total cell population, where i = 1, 2, 3, 4.
• Activation of both cell growth and cell death of species Ci by signal Aj is governed by a first
order Hill function with a dissociation constant KAi , where j = 1, 2, 3, 4, and i = 1, 2, 3, 4.
• The dilution/basal death rate of cells is much slower than the kinetics of induced death rate
in the circuit; thus dilution/basal death rates are negligible. Lysis induced death of C1 and
C2 is activated by A2 and A4 respectively.
• The production of signal species Aj is characterized by its maximal rate of gAj .
• The dilution/degradation rate of signal species Aj is described as dAj .
We obtain the following model for all acute wound healing cellular species C1, C2, C3, and C4, as
well as signaling species A1, A2, A3 and A4. The first term in equations (1-3) represents recruiting
C1, C2, and C3 with signals µ, A1, and A3 respectively. Once cells are present, recruitment stops,
and signal induced cell growth is activated.
dC1
dt = µ · ( KrcKrc+C21 ) + gc1 · C1 · (
µ
Kµ+µ
) · (1− ΣCiCmax )− dLC1 · ( A2KA2+A2 ) · C1 (1)
dC2
dt = A1 · ( KrcKrc+C22 ) + gc2 · C2 · (
A1
KA1+A1
) · (1− ΣCiCmax )− dLC2 · ( A4KA4+A4 ) · C2 (2)
dC3
dt = A3 · ( KrcKrc+C23 ) + gC3 · C3 · (
A3
KA3+A3
) · (1− ΣCiCmax )− gC4 · C3 (3)
dC4
dt = gC4 · C3 (4)
dA1
dt = gA1 · C1 − dA ·A1 (5)
dA2
dt = gA2 · C2 − dA ·A2 (6)
dA3
dt = gA3 · C2 − dA ·A3 (7)
dA4
dt = gA4 · C3 − dA ·A4 (8)
As mentioned earlier, the first layer of the control systems is a simulation of cellular popula-
tion dynamics that represents that of physiological acute healing. In our simulation, species C4
represents complete wound contraction (healthy). Upon injury, via activation of input signal µ, we
simulate breaching of the skin barrier (setting initial condition of C4 to zero), while simultaneously
inducing the growth of species C1 (initiation of inflammation phase) as shown in equation (1).
The first term in equation (1) describes the recruitment of C1 into the system. This recruitment is
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Table 1: Summary of species in our wound healing model
Species Description
C1 Population of C1
C2 Population of C2
C3 population of C3
C4 Population of C4
A1 AHL signal produced in C1
A2 AHL signal produced in C2
A3 AHL signal produced in C2
A4 AHL signal produced in C3
turned off as soon as a small amount of C1 is present. After the recruitment, the species µ regulates
the growth of C1 at the maximum rate of gC1 .
As the C1 population increases, the constitutive expression of signaling molecule A1 accumulates
both in the cell and globally at a rate of gA1 as described in equation (5). We assume permeation
of the signal is instantaneous, therefore the concentration of the signal inside and outside of the cell
is the same. Species A1 activates the growth of C2 (similar of the mechanism of µ activating C1),
equation (2). Cell species C2 constitutively produces two signals, A2 in equation (6) and signal
A3 in equation (7). While A2 negatively regulates C1 by activating its death at rate dLC1 , A3
progresses healing to the next phase by recruiting C3, equation (3).
In physiological wound healing, species C2 (macrophage) serves two purposes: (1) finishing the
debridement function of the inflammatory phase (lowering concentration of C1), and (2) activating
anti-inflammatory signals for the recruitment of fibroblasts C3 (proliferation phase). Once acti-
vated, C3 produces a signal A4 that negatively regulates C2 by activating the death of C2. With
species C1 no longer in the system, and species C2 approaching its depletion, C3 becomes the
dominant cell type in the wound. Physiologically, at this stage, the fibroblast is responsible for
establishing wound closure by secreting collagen.
Once collagen is placed in the wound, the final healing stage is activated. At this stage, the
wound is free of any damaged cellular debris and pathogens from injury through the C1 and C2
phases, and has a strong, functional matrix of collagen. The final stage of wound healing, wound
contraction, is governed by the differentiation of fibroblasts into myofibroblasts, modeled as C3
converting to C4 as shown in equation (4). Based on parameters listed in Table 2, the acute wound
healing model demonstrates the similar sequential relay dynamics found in physiological wound
healing (Figure 1C).
We further analyzed the cellular dynamics of our first layer acute healing circuit design. In
Figure 2, the introduction of population disturbances were simulated by decreasing the cellular
concentrations of C1 through C4 during their respective phase of healing. Perturbing cellular
species resulted in minimal delay in healing and alterations to cellular dynamics of each of the
cell types in the system. Notice the perturbations of C2 in Figure 2B slightly delay healing. This
is because species C2 is responsible for activating the death of C1, as well as the growth of C3.
Perturbing the population of C2 allows for the prolonged presence of C1, delaying overall healing.
A perturbations of C4 when approaching its peak density (complete healing), simulate a secondary
injury within the original wounded region, triggering the cascading dynamics of healing starting
from the first stage, growth of C1 (Figure 2D).
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Table 2: Summary of parameters in our would healing model
Parameters Description Value
gC1 Cell growth rate of C1 1.5 h
−1
gC2 Cell growth rate of C2 1.5 h
−1
gC3 Cell growth rate of C3 2.8 h
−1
gC4 Rate of differentiation of C3 to C4 0.08 h
−1
gA1 Rate of A1 production in C1 5 nM h
−1
gA2 Rate of A2 production in C2 5 nM h
−1
gA3 Rate of A3 production in C3 5 nM h
−1
gA4 Rate of A4 production in C4 5 nM h
−1
Cmax Maximal cell density 100 cells
Kµ Activating/repression constant of µ 1 nM
KA1 Activating/repression constant of A1 200 nM
KA2 Activating/repression constant of A2 200 nM
KA3 Activating/repression constant of A3 400 nM
KA4 Activating/repression constant of A4 400 nM
Krc Species recruiting constant 0.1 nM
dCR Natural cell death rate of R1 and R2 0.1 h
−1
dLC1 Maximal C1 death rate due to lysis 0.6 h
−1
dLC2 Maximal C2 death rate due to lysis 0.6 h
−1
dA Deg. rate of signaling molecules 0.5 h
−1
µ Inducer signal species initiating propagation 0 or 1
C1 Perturbation C2 Perturbation
C3 Perturbation C4 Perturbation
BA
DC
0 50 100 150
Time (hr)
0
25
50
75
100
C
el
ln
um
be
r
0 50 100
0
25
50
75
100
C
el
ln
um
be
r
150
Time (hr)
0 50 100
0
25
50
75
100
150
Time (hr)
C
el
ln
um
be
r
C1 C2 C3 C4
0 50 100 150
Time (hr)
0
25
50
75
100
C
el
ln
um
be
r
Figure 2: Cellular density perturbation in acute wound healing. Perturbations resulting in
the removal of each cell type at their respective times: A. depletion of species C1 at t = 28 hr, B.
depletion of species C2 at t = 40 hr, C. depletion of species C3 at t = 47 hr, and D. depletion of
species C4 at t = 80 hr. 6
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Chronic wound healing conditions
Whether caused by dermal injury or surgical procedure, acute wound healing progresses steadily and
predictably through all of the healing stages. Ultimately, the time span and outcome of acute healing
will depend on the wound’s location, size, depth, and trauma type. Chronic wounds, on the other
hand, are defined as wounds that have not fully healed, normally surpassing 30 days of recovery.
Many factors including oxygenation, infection, age, stress, diabetes, medications, and nutrition, are
known to interfere with the wound’s ability to progress through normal healing [18, 19].
The orchestrated interactions of various cell types, extra-cellular components, growth factors,
and cytokines together play important roles in each of the different stages during healing [20].
Therefore, an imbalance to any of these elements may lead to either prolonged healing, or excessive
scarring. Most commonly, chronic wounds are thought to be stalled in either the inflammatory
phase or the proliferative phase [21, 22]. There are many factors in physiological wound healing
that can go awry, leading to non-healing wounds. In this section we focus on four conditions that
lead to hyper-inflammation. In Figure 3, we analyze the sequential population dynamics of chronic
wound conditions based on the following scenarios:
• Figure 3A: Hyper-inflammation condition caused by low A1 signal production (gA1) in cell
C1. In this system, we have prolonged activation of C1, which does not properly recruit C2
into the system. Without C2, the wound will remain stuck in the hyper-inflammatory state.
In a healthy wound environment, neutrophils recruit the second inflammatory cell species
macrophages (C2), for healthy healing progression. Macrophages play an important role in
wound debridement as well as the initiation of the proliferation stage.
• Figure 3B: Hyper-inflammation condition caused by low A2 signal production (gA2) in cell C2.
Similar to the results of Figure 3A, low A2 production allows for species C1 to persist in the
wound. The action of macrophage phagocytosis of neutrophils (C1) is modeled as inducible
lysis gene expression. The extended presence of neutrophils may result in increased levels of
pro-inflammatory signals, resulting in chronic wound healing.
• Figure 3C: Hyper-inflammation conditions caused by a low production rate of signal A3 in
cell C2. This simulates low proliferation of fibroblasts or a slow transition rate from the
inflammatory phase to the proliferation phase. Signal A3 is used to activated the growth of
species C3. When the rate of A3 signal production is low, the wound gets stuck in oscillatory
dynamics between C1 and C2. Physiologically, an improper transition from the inflammatory
phase to the proliferation phase could result in increased tissue damage and increased infection
rate.
• Figure 3D: Chronic wound healing dynamics of an impaired inflammation to proliferation,
simulated with a slow production rate of signal A4 in cell C3. Recruited fibroblasts initiate
the reconstruction phase in the wound by secreting many ECM signals. ECM signals along
with the influx of fibroblasts into the injury site, are responsible for the transition of pro-
inflammatory macrophage cells M1 into anti-inflammatory macrophage cells M2. In cases
where the fibroblast function is low, M1 macrophages persist reverting the wound back into
a chronic inflammatory condition.
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Figure 3: Simulations of chronic wound healing dynamics. A. Low production rate of
signal A1 (gA1), which recruits C2. B. Low production rate of signal A2 (gA2), which induces lysis
expression in C1. C. Low production rate of signal A3 (gA3), which induces proliferation (growth)
of cell C3 D. Low production rate of signal A4 (gA4), which induces lysis expression in C2.
Regulator cells design strategy
Table 3: Parameters for the regulator cells
Parameters Description Value
gA2R1 Rate of A2 production in R1 4 nM h
−1
gA4R2 Rate of A4 production in R2 1 nM h
−1
K1R1 Activating/repression constant of A1 in R1 5 nM
K2R1 Activating/repression constant of A2 in R1 400 nM
K3R2 Activating/repression constant of A3 in R2 400 nM
K4R2 Activating/repression constant of A4 in R2 1000 nM
As described earlier, our wound healing circuit consists of two negative feedback modules sharing
a common cell type, species C2: (1) C1 activating C2 growth while C2 represses C1 (activating death)
and (2) C2 activating C3 growth while C3 represses C2 (also activating death). These interactions
are shown in Figure 4A.
Here we designed regulator cells, keeping in mind the physiological rules of timely and functional
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acute wound healing. We propose two coupled type–1 IFFL regulator cells to produce signaling
pulses, illustrated in Figure 4 under desired conditions [23, 24]. Species R1 receives input A1 and
produces output A2. When signal A2 is low, signal A1 is secreted from wound healing species C1.
A high concentration of C1 activates the production of A2 in the wound environment, promoting
the death of C1. In summary, high A1 and low A2 conditions results in pulsed A2 production in
R1, preventing the persistence of high C1 hyper-inflammation. Due to the negative auto-regulation
of A2 in R1, the production of A2 from R1 is turned off as soon as A2 becomes abundant enough to
prevent further potential interference between controller cells and the wound tissues. The second
controller R2 is identical to R1, with signal A3 as the input signal and A4 as the output signal.
Figure 4A illustrates the detailed interaction between the wound dynamics and the regulator cells
where equation (6) and equation (8) in the acute wound healing model are updated into equation
(9) and equation (10), respectively.
dA2
dt = gA2 · C2 + gA2R1 · A1(K1R1+A1) ·
K2R1
(K2R1+A2)
·R1 − dA ·A2 (9)
dA4
dt = gA4 · C3 + gA4R2 · A3(K3R2+A3) ·
K4R2
(K4R2+A4)
·R2 − dA ·A4 (10)
A1 A2 R1 output (A2)
0 0 0
0 1 0
1 0 1
1 1 0
A3 A4 R2 output (A4)
0 0 0
0 1 0
1 0 1
1 1 0
A
B
C1 C2 C3
R2R1
C4
A4
A3
A4
A3
A2
A1
A1
A2
input input
Figure 4: Regulator design: Two coupled incoherent feed-forward loop circuits. A.
Circuit diagram of layer 1 wound healing circuit, coupled with layer 2 circuit that consists of two
pulse generating regulator cells R1 and R2. B. Truth table describing the logic of the regulator
cells producing output species A2 and A4 in response to the environmental signals.
Using the chronic wound condition parameters, we analyzed the effectiveness of our regulator
controller cells against selected chronic conditions. Simulations of chronic healing dynamics in the
presence of regulator cells shown in Figure 5 demonstrate the controller’s ability to improve the
altered cellular dynamics associated with chronic healing. Our coupled pulse generating regulator
9
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cells recover acute healing dynamics of some chronic conditions better than others. For example, in
chronic conditions of low ga1 and low ga3, the sequential dynamics of each cell species are drastically
improved. However, wound closure is not complete (Figures 5A and 5C). Alternatively, ideal wound
closure, modeled as total cell number of species C4 becoming 100% of the cellular population in a
timely manner, is observed in conditions with low ga2 and low ga4 signals production (Figures 5B
and 5D).
The regulator cells are most effective when signals A1 and A3 are abundant, but A2 and A4 are
sparse. A low production rate of signal A3 proves to be difficult to regulate against chronic hyper-
inflammatory conditions. This is because R2 requires an abundance of A3 to activate the production
of signal A4, to assist in healing progression. If signal A3 is absent (or low), the activation of the
signal production of A4 in the regulator cell R2 is not effective in restoring healing dynamics (as
shown in Figure 5C. However, if you compare the unregulated chronic dynamics (Figure 3C), to the
dynamics of the regulated system, you will notice the healing dynamics improve due to decreased
oscillatory dynamics of species C1, C2, and C3, although the final population of C4 does not change.
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Figure 5: Simulations of chronic to acute wound healing dynamics with regulator cells.
A. Low production rate of signal A1 (gA1), used to recruit C2. B. Low production rate of signal
A2 (gA2), used to induce lysis expression in C1. C. Low production rate of signal A3 (gA3), used
to induce proliferation of cell C3 D. Low production rate of signal A4 (gA4), used to induce lysis
expression in C2.
We also analyzed the stability of healing dynamics of the acute healing circuit layer by per-
turbing the growth rate, the death rate, and the signal production rate parameters of each cellular
species in our circuit design. For example, in Figure 6, top row (i), we compare the system’s stabil-
ity to C1 growth rate (gC1), the production rate of signal A2 (gA2), and C1 death rate (dLC1) both
in the absence (panel A) and presence (panel B) of regulator cells. Parameter perturbations were
10
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studied by either decreasing or increasing values listed parameter values in Table 2 as low as 0.1x
and as high as 10x. Regulator cells are effective in increasing healing robustness when perturbing all
signal synthesis parameters gA1 , gA2 , gA3 , and gA4 . Contrarily, regulator cells struggle to improve
healing dynamics of system sensitivity to cellular growth and death rates.
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Figure 6: Analysis of the wound healing circuit dynamic stability to parameter per-
turbations. A. Simulations of circuit stability with parameter perturbations in the absence of
regulator cells. B. Simulations of circuit stability with parameter perturbations in the presence of
regulator cells. Parameter perturbations from 0.1 to 7.0 times ideal parameters listed in Table 2
acting on species (i.) C1, (ii.) C2, (iii.) C3. Healing accuracy is a measurement of complete and
timely healing defined by the concentration of species C4 at time 150 hours. For example, 100%
accuracy is species C4 reaching max concentration at time 150 hours.
Discussion
Wound healing is a fundamental, yet complicated phenomenon developed to protect the host from
intrusion of harmful pathogens. Chronic wound healing and effective treatments are important
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concerns for health care professionals. By taking advantage of new findings of signaling pathways
and mechanistic relationships [25], we can better predict the stages of wound healing [26], develop
anti-scarring therapies [27], better treat burn injuries, skin cancers, angiogenesis [28], and other
chronic wound conditions [29].
Given the importance of signaling factors [30], there awaits new discoveries by coupling syn-
thetic biology and wound healing signals for advanced treatments [31]. Computational studies on
wound healing have provided the necessary insight into the molecular dynamics of wound healing
phases, and the inter-connectedness of the complex signaling network. Researchers are currently ap-
plying classical control theory concepts to biological systems for sustainable mammalian-microbial
interactions [32, 33, 34]. Implementing feedback controllers for regulation of immunological chronic
diseases may prove to be a hands-off, stable solution for positively regulating complex network
systems consisting of engineered multi-layered networks [35].
In this work we developed a simple model mimicking the cellular dynamics of wound healing,
and designed biological controllers that can be embedded in a healing salve or placed on a bandage.
Our computational approach focuses on the elucidation of control systems needed to sense and
regulate against impaired dynamics of a sequential signaling network. We propose a multiple layer
population controller consisting of a wound healing circuit that demonstrates cellular population
dynamics of acute physiological wound healing (layer 1), and the coordination of feedback controllers
that sense chronic dynamics, improving the system’s cellular dynamics to resemble acute healing
(layer 2). In this paper we (1) simulate a four node wound healing process that resembles cellular
dynamics found in physiological healing, (2) implement predictive chronic wound healing dynamics,
and (3) regulate against hyper-inflammation and impaired proliferation chronic conditions using
closed-loop controllers. Although we found conditions where our regulator controllers proved to be
effective, there were still conditions in which our controllers failed to improve the chronic wound
dynamics. x
We demonstrated the ability to use pulse generating motifs to sense temporal changes in chem-
ical concentrations and cellular densities to predict and fix chronic conditions. We plan to continue
to improve both the wound healing testbed layer, as well as develop more combinatorial network
motif controllers to regulate against many more chronic conditions robustly. Having developed this
model based on E. coli dynamics, we plan to build an experimental wound healing demonstration
based on population controls and negative feedback motifs for predictable dynamics.
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